The Impact of Treatment of Hepatocellular Carcinoma With Immune Checkpoint Inhibitors on Pre- and Post-liver Transplant Outcomes

Transplantation. 2022 Jun 1;106(6):e308-e309. doi: 10.1097/TP.0000000000004108. Epub 2022 May 23.

¹ Division of Gastroenterology & Hepatology, Department of Medicine, University of California, San Diego, CA.
² School of Public Health, University of California, San Diego, CA.
³ Division of Transplant and Hepatobiliary Surgery, Department of Surgery, University of California, San Diego, CA.
⁴ Altman Clinical and Translational Research Institute (ACTRI), University of California, San Diego, CA.
⁵ University of California, San Diego School of Medicine, San Diego, CA.

No abstract available

Publication types